ICS 2012 Report ‘‘Next Monday, you are Minister for Health. Now what?’’
by Edel O’Connell reporting on the Stokes Lecture by Professor Ian Graham.
by Edel O’Connell reporting on the Stokes Lecture by Professor Ian Graham.
by Edel O’Connell – CARDIAC medicine has come a long way in 50 years but the dual pressures of cutbacks in the health service and an increased sedentary… read more.
by Bruce Sylvester – Following a systematic review of 26 relevant studies involving 2,959 women, Cochrane Review researchers concluded that inhaled pain relief appears to offer safe and… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – Over 1,000 small and medium enterprises (SMEs) have now registered with European Medicines Agency SME office. The… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The CHMP has recommended the first medical treatment for the removal of eschar from severe burn wounds.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The EMA has given the green light for the first medicine specifically for irritable bowel syndrome (IBS)… read more.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – There’s a new man at the helm of the European Medicine Agency’s most influential committee: Dr Tomas… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Adalimumab appears to be effective in maintaining remission among some pediatric patients with Crohn’s disease.
by Bruce Sylvester – Emerging use of FDA Approved Drugs – Maraviroc, an antiretroviral drugin the treatment of HIV, significantly reduces the incidence of graft-versus-host disease (GvHD) among… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – In some patients severe aplastic anemia who have failed standard therapies, eltrombopag appears to raise blood cell… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Botulinum toxin treatment appears to improve tremor in the arms and hands of persons with multiple sclerosis… read more.
by Bruce Sylvester – Older seniors, aged 85 and over, show a high burden of respiratory disease, researchers reported on September 3, 2012 at the European Respiratory Society’s… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.